1. Jackson T, Belsham GJ. Picornaviruses: A View from 3A. Viruses 2021; 13: 456.
2. Abdullah SW, Wu J, Wang X, Guo H, Sun S. Advances and Breakthroughs in IRES-Directed Translation and Replication of Picornaviruses. mBio 2023; 25: 14.
3. https://ictv.global/report/chapter/picornaviridae/picornaviridae
4. Cathcart A, Baggs EL, Semler BL. Picornaviruses: Pathogenesis and Molecular Biology. In: Reference Module in Biomedical Sciences. 3rd edition. 2015.
5. Lu L, Ashworth J, Nguyen D, Li K, Smith DB, Woolhouse M, On Behalf Of The Vizions Consortium. No Exchange of Picornaviruses in Vietnam between Humans and Animals in a High-Risk
Cohort with Close Contact despite High Prevalence and Diversity. Viruses 2021; 27:13:1709.
6. Walker PJ, Siddell SG, Lefkowitz EJ, et al. Changes to virus taxonomy and to the International Code of Virus Classification and Nomenclature ratified by the International Committee on
Taxonomy of Viruses (2021). Arch Virol 2021; 166: 2633-2648.
7. Payne S. Family Picornaviridae. In: Washington K, ed. Viruses From Understanding to Investigation. 2nd edition. London, Academic press; 2022.
8. Virus genomes and their replication. In: Rybicki EP, ed. Cann’s principles of molecular virology. 7th edition. London, Academic Press; 2023
9. Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 2018; 16 : 368-381.
10. Enteroviruses. In: Ryan KJ, ed. Sherris and Ryan’s Medical Microbiology. 8th edition. New York, McGraw Hill; 2022
11. Cifuente JO, Moratorio G. Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion. Front Cell Infect Microbiol 2019; 9:283.
12. Picornavirus. In: Wang-Shick Ryu WS, ed. Molecular Virology of Human Pathogenic Viruses. London, Academic Press; 2017.
13. Peng T, Yang F, Yang F, Cao W, Zheng H, Zhu Z. Structural diversity and biological role of the 5’ untranslated regions of picornavirus. RNA Biol 2023; 20: 548-562.
14. Andino R, Kirkegaard K, Macadam A, Racaniello VR, Rosenfeld AB. The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens. J Infect Dis
2023; 228 :S427–445.
15. Zhu P, Ji W , Li D, et al. Current status of hand-foot-and-mouth disease. J Biomed Sci 2023; 30:15.
16. Kinobe R, Wiyatno A, Artika M, Safari D. Insight into the Enterovirus A71: A review. Rev Med Virol. 2022;32:e2361.
17. Wang C, Li J, Liu Y, Qiang Sun Q, Liu Z. Pathogenesis of enterovirus infection in central nervous system. Biosaf Health 2023; 5: 233–239.
18. Savolainen-Kopra C, Blomqvist S, Susi P. Picornaviridae. In: Bamford D, Zuckerman M, eds. Encyclopedia Virology. 4 th edition. Amsterdam, Academic Press; 2021.
19. Steil BP, Barton DJ. Cis-Active RNA Elements (CREs) and Picornavirus RNA Replication. Virus Res 2009; 139: 240–252.
20. Elrick MJ, Pekosz A, Duggal P. Enterovirus D68 molecular and cellular biology and pathogenesis. J. Biol. Chem 2021; 296: 100317.
21. Abdelnabi R, Baggen J, Mirabelli C, Neyts J. Antiviral strategies against (Non-polio) picornaviruses. Rübsamen-Schaeff H, Buschmann H, eds. New drug development for known and emerging
viruses. Weinheim, Wiley-VCH; 2022.
22. P. Simmonds P, Gorbalenya AE, Harvala H, et al. Recommendations for the nomenclature of enteroviruses and rhinoviruses. Arch Virol 2020; 165:793–797.
23. Chaldam Jespère Mbani CJ, Nekoua MP, Moukassa D, Hober D. The fight against poliovirus is not over. Microorganisms 2023; 11; 1323.
24. Chen BS, Lee HC, Lee KM, Gong YN, Shih SR. Enterovirus and Encephalitis. Front. Microbiol 2020; 11:261.
25. Itani T, Chalapa V, Semenov A, Sergeev A. Laboratory diagnosis of nonpolio enteroviruses: A review of the current literatüre. Biosaf Health 2023; 5: 112–119.
26. Filipe IC, Guedes MS, Zdobnov EM, Tapparel C. Enterovirus D: A Small but Versatile Species. Microorganisms 2021; 9: 1758.
27. Enterovirus, Parechovirus, and Reovirus Infections. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, eds. Harrison’s Principles of Internal Medicine. 21th edition.
McGraw Hill, 2022.
28. Harvalaa H, Brobergb E, Benschop K, et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol 2018; 101: 11–17.
29. Kima CY, Piamonteb B, Allenc R, Thakura KT. Threat of resurgence or hope for global eradication of poliovirus?. Curr Opin Neurol 2023; 36: 229-237.
30. Estivariz CF; Link-Gelles R, Shimabukuro T. Poliomyelitis, hepatitis A In: Hall E, Wodi AP, Hamborsky J, Morelli V, Schillie S, eds. Epidemiology and Prevention of Vaccine-Preventable
Diseases. 14 th edition. CDC. 2021.
31. Mohanty A, Rohilla R, Zaman K. Vaccine Derived Poliovirus (VDPV). Le Infezioni in Medicina 2023; 2: 174-185.
32. Blondel B, Colbère-Garapin F, Couderc T, Wirotius A, Guivel-Benhassine F. Poliovirus, pathogenesis of poliomyelitis, and apoptosis. Curr Top Microbiol Immunol 2005; 289: 25-56.
33. Estivariz CF, Kovacs SD, Mach O. Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks. Vaccine 2023; 41:
A113–A121.
34. https://microbenotes.com/polio-virus/
35. Cooper LV, Ananda S Bandyopadhyay AS, Gumede N, et al. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and
the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa. Lancet Infect Dis 2022; 22: 284–294.
36. https://polioeradication.org/wp-content/uploads/2023/06/GPEI_nOPV2_Factsheet_31-May-2023.pdf
37. Souverbiellea CT, Erdema G, Sánchez PJ. Update on nonpolio enterovirus and parechovirus infections in neonates and young infants. Curr Opin Pediatr 2023; 35: 380-389.
38. Brouwer L, Moreni G, Katja C. Wolthers KC, Pajkrt D. World-Wide Prevalence and Genotype Distribution of Enteroviruses. Viruses 2021;13: 434.
39. Korukluoglu G, Ozdemirer U, Bayrakdar F, et al. Detection of non-polio and polio enteroviruses in Acute Flaccid Paralysis surveillance in Turkey. Acta Microbiol Immunol Hung 2021; 68:
92–98.
40. Andino R, Kirkegaard K, Macadam A, Racaniello VR, Rosenfeld AB. The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens. JID 2023;
228: (Suppl 6).
41. Zhang X, Zhang Y, Li, H, Liu L. Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines. Int J Mol Sci 2023; 24: 169.
42. Alhazmi A, Nekoua MP, Mercier A. Combating coxsackievirus B infections. Rev Med Virol 2023; 33: e2406.
43. Ianevski A, Zusinaite E, Tenson T. Novel Synergistic Anti-Enteroviral Drug Combinations. Viruses 2022; 14: 1866.
44. Ljubin-Sternak S, Meštrovi´c T. Rhinovirus—A True Respiratory Threat or a Common Inconvenience of Childhood?. Viruses 2023; 15: 825.
45. Jiang H, Yang T, Yang C. Molecular epidemiology and clinical characterization of human rhinoviruses circulating in Shanghai, 2012-2020. Arch Virol 2022; 167:1111–1123.
46. Toufik Abdul-Rahman T, Nazir A, Khater B, et al. Increased rhinovirus/enterovirus infections including Ev-D68 in the United States, a challenge for healthcare providers amidst inf luenza
virus infection and the COVID-19 pandemic. Postgrad Med J 2023; 99; 372–374.
47. Das A, Rivera-Serrano EE, Yin X, Walker CM, Feng Z, Lemon SM. Cell entry and release of quasi-enveloped human hepatitis viruses. Nat Rev Microbiol 2023; 21: 573–589.
48. Gholizadeh O, Akbarzadeh S, Hashemi MG, et al. Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination. Can J Infect Dis Med Microbiol
2023; 36: 4263309.
49. https://www.cdc.gov/hepatitis/statistics/surveillanceguidance/HepatitisA.htm
50. Razizadeh MH, Khatami A, Zarei M. Global Status of Bufavirus, Cosavirus, and Saffold Virus in Gastroenteritis: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2022; 13:
775698.